Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus and Cetuximab in Advanced Solid Tumors
NCT02215720Phase 1Completed
- Sponsor
- Gustave Roussy
- Start
- Apr 2011
- Primary completion
- Sep 2014
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of temsirolimus and KL-140 in solid tumor, sponsored by Gustave Roussy. Primary endpoint: Safety up to 24 months. Started Apr 2011; status: completed.
02
Drugs
temsirolimusKL-140
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02215720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215720.